BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26088135)

  • 41. Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis.
    Das R; Datta R; Varadarajan R
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A functional interaction between gp41 and gp120 is observed for monomeric but not oligomeric, uncleaved HIV-1 Env gp140.
    Guttman M; Lee KK
    J Virol; 2013 Nov; 87(21):11462-75. PubMed ID: 23966389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins.
    Sellhorn G; Kraft Z; Caldwell Z; Ellingson K; Mineart C; Seaman MS; Montefiori DC; Lagerquist E; Stamatatos L
    J Virol; 2012 Jan; 86(1):128-42. PubMed ID: 22031951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stabilizing the native trimer of HIV-1 Env by destabilizing the heterodimeric interface of the gp41 postfusion six-helix bundle.
    Kesavardhana S; Varadarajan R
    J Virol; 2014 Sep; 88(17):9590-604. PubMed ID: 24920800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer.
    Lee JH; Ozorowski G; Ward AB
    Science; 2016 Mar; 351(6277):1043-8. PubMed ID: 26941313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
    Zhang MY; Yuan T; Li J; Rosa Borges A; Watkins JD; Guenaga J; Yang Z; Wang Y; Wilson R; Li Y; Polonis VR; Pincus SH; Ruprecht RM; Dimitrov DS
    PLoS One; 2012; 7(9):e44241. PubMed ID: 22970187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.
    Schorcht A; Cottrell CA; Pugach P; Ringe RP; Han AX; Allen JD; van den Kerkhof TLGM; Seabright GE; Schermer EE; Ketas TJ; Burger JA; van Schooten J; LaBranche CC; Ozorowski G; de Val N; Bader DLV; Schuitemaker H; Russell CA; Montefiori DC; van Gils MJ; Crispin M; Klasse PJ; Ward AB; Moore JP; Sanders RW
    J Virol; 2022 Jan; 96(1):e0155221. PubMed ID: 34669426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a RPLC-UV method for monitoring uncleaved HIV-1 envelope glycoprotein.
    Schneck NA; Vinitsky AL; Ivleva VB; Wang X; Gowetski DB; Lei QP
    Anal Methods; 2021 May; 13(19):2183-2188. PubMed ID: 33954330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.
    Zhang P; Gorman J; Geng H; Liu Q; Lin Y; Tsybovsky Y; Go EP; Dey B; Andine T; Kwon A; Patel M; Gururani D; Uddin F; Guzzo C; Cimbro R; Miao H; McKee K; Chuang GY; Martin L; Sironi F; Malnati MS; Desaire H; Berger EA; Mascola JR; Dolan MA; Kwong PD; Lusso P
    Cell Host Microbe; 2018 Jun; 23(6):832-844.e6. PubMed ID: 29902444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers.
    Khayat R; Lee JH; Julien JP; Cupo A; Klasse PJ; Sanders RW; Moore JP; Wilson IA; Ward AB
    J Virol; 2013 Sep; 87(17):9865-72. PubMed ID: 23824817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures.
    Harris A; Borgnia MJ; Shi D; Bartesaghi A; He H; Pejchal R; Kang YK; Depetris R; Marozsan AJ; Sanders RW; Klasse PJ; Milne JL; Wilson IA; Olson WC; Moore JP; Subramaniam S
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11440-5. PubMed ID: 21709254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates.
    Verkerke HP; Williams JA; Guttman M; Simonich CA; Liang Y; Filipavicius M; Hu SL; Overbaugh J; Lee KK
    J Virol; 2016 Oct; 90(20):9471-82. PubMed ID: 27512064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.
    Kumar R; Ozorowski G; Kumar V; Holden LG; Shrivastava T; Patil S; Deshpande S; Ward AB; Bhattacharya J
    J Biol Chem; 2017 Sep; 292(38):15849-15858. PubMed ID: 28743743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.
    Schülke N; Vesanen MS; Sanders RW; Zhu P; Lu M; Anselma DJ; Villa AR; Parren PW; Binley JM; Roux KH; Maddon PJ; Moore JP; Olson WC
    J Virol; 2002 Aug; 76(15):7760-76. PubMed ID: 12097589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conserved structures exposed in HIV-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and potential immunogens.
    Chow YH; Wei OL; Phogat S; Sidorov IA; Fouts TR; Broder CC; Dimitrov DS
    Biochemistry; 2002 Jun; 41(22):7176-82. PubMed ID: 12033952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates.
    Chakrabarti BK; Feng Y; Sharma SK; McKee K; Karlsson Hedestam GB; Labranche CC; Montefiori DC; Mascola JR; Wyatt RT
    J Virol; 2013 Dec; 87(24):13239-51. PubMed ID: 24067980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties.
    Guenaga J; de Val N; Tran K; Feng Y; Satchwell K; Ward AB; Wyatt RT
    PLoS Pathog; 2015 Jan; 11(1):e1004570. PubMed ID: 25569572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
    Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
    Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
    J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: characterization and ligand binding analysis.
    Pancera M; Lebowitz J; Schön A; Zhu P; Freire E; Kwong PD; Roux KH; Sodroski J; Wyatt R
    J Virol; 2005 Aug; 79(15):9954-69. PubMed ID: 16014956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.